34 min listen
New Audio Updates: CCO Independent Conference Coverage of Hepatitis B at AASLD 2023
New Audio Updates: CCO Independent Conference Coverage of Hepatitis B at AASLD 2023
ratings:
Length:
37 minutes
Released:
Feb 5, 2024
Format:
Podcast episode
Description
In this episode, Nancy Reau, MD, discusses new data on hepatitis B virus presented at AASLD 2023, including:Current therapiesStudies 108 and 110: Factors Linked With Lack of Virologic Suppression After 8 Yr of TAF or TDFKaiser Permanente Northern California: HCC or Death With TDF vs ETV for Chronic Hepatitis BEarly vs Late Postpartum Cessation of TDF Initiated for Prevention of Vertical HBV TransmissionInvestigational functional cure strategiesB-Together: Sequential Bepirovirsen and PegIFN Added to NA Therapy for Chronic HBV InfectionMARCH Part B: VIR-3434 ± VIR-2218 ± PegIFN Added to NA Therapy for Chronic HBV InfectionREEF-IT: JNJ-3989 + NA ± JNJ-6379 With PegIFN Add-on Consolidation in Patients With HBeAg-Positive CHBHBV003: VTP-300 + Nivolumab Added to NA Therapy for Chronic HBV InfectionCVP-NASVAC: Nasally Administered Therapeutic Vaccine for Chronic HBV InfectionPresenter:Nancy Reau, MDProfessor of MedicineRichard B. Capps Chair of HepatologyChief, Section of HepatologyAssociate Director, Solid Organ TransplantationRush University Medical Center Chicago, IllinoisLink to full program: https://bit.ly/47XJlU4
Released:
Feb 5, 2024
Format:
Podcast episode
Titles in the series (100)
COVID-19: Answering the Questions, Part 7: In Part 7 of this ongoing 12-part COVID-19 series, listen to a brief update on COVID-19 risk and prevention strategies among healthcare workers by Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS. by CCO Infectious Disease Podcast